Michelle Keramidas
Overview
Explore the profile of Michelle Keramidas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Josserand V, Lavaud J, Keramidas M, Collet C, Traboulsi W, Hoffmann P, et al.
Methods Mol Biol
. 2023 Nov;
2728:131-136.
PMID: 38019397
Normal fetal growth and placental development depend on active angiogenesis occurring at the fetomaternal interface throughout pregnancy. Nevertheless, reliable in vivo methods to assess placental angiogenesis are still missing. Here,...
2.
Boudria A, Faycal C, Jia T, Gout S, Keramidas M, Didier C, et al.
Oncogene
. 2023 Jul;
42(32):2471-2472.
PMID: 37407792
No abstract available.
3.
Boudria A, Faycal C, Jia T, Gout S, Keramidas M, Didier C, et al.
Oncogene
. 2018 Sep;
38(7):1050-1066.
PMID: 30194450
Vascular endothelial growth factor-A (VEGF-A) is highly subjected to alternative pre-mRNA splicing that generates several splice variants. The VEGF and VEGFb families encode splice variants of VEGF-A that differ only...
4.
Martel-Frachet V, Keramidas M, Nurisso A, DeBonis S, Rome C, Coll J, et al.
Oncotarget
. 2015 Jun;
6(16):14669-86.
PMID: 26036640
We previously identified 1-(2,4-dimethoxyphenyl)-3-(1-methylindolyl) propenone (IPP51), a new chalcone derivative that is capable of inducing prometaphase arrest and subsequent apoptosis of bladder cancer cells. Here, we demonstrate that IPP51 selectively...
5.
Salomon A, Keramidas M, Maisin C, Thomas M
Oncotarget
. 2015 Apr;
6(13):11421-33.
PMID: 25823656
Adrenal carcinoma (ACC) is a rare neoplasm with a poor outcome. Aberrant expression of β-catenin has been found in approximatively 30% of ACC. We herein studied its effects on the...
6.
Desroches-Castan A, Quelard D, Demeunynck M, Constant J, Dong C, Keramidas M, et al.
Oncotarget
. 2015 Mar;
6(7):5382-411.
PMID: 25742784
The efficacy of anti-angiogenic therapies on cancer patients is limited by the emergence of drug resistance, urging the search for second-generation drugs. In this study, we screened an academic chemical...
7.
Yameogo J, Geze A, Choisnard L, Putaux J, Mazet R, Passirani C, et al.
Eur J Pharm Biopharm
. 2014 Sep;
88(3):683-94.
PMID: 25204521
In a previous study, we reported on the formulation of Artemisinin-loaded surface-decorated nanoparticles (nanospheres and nanoreservoirs) by co-nanoprecipitation of PEG derivatives (PEG1500 and PEG4000-stearate, polysorbate 80) and biosynthesized γ-CD fatty...
8.
Faurobert E, Rome C, Lisowska J, Manet-Dupe S, Boulday G, Malbouyres M, et al.
J Cell Biol
. 2013 Aug;
202(3):545-61.
PMID: 23918940
The endothelial CCM complex regulates blood vessel stability and permeability. Loss-of-function mutations in CCM genes are responsible for human cerebral cavernous malformations (CCMs), which are characterized by clusters of hemorrhagic...
9.
Jacquart A, Keramidas M, Vollaire J, Boisgard R, Pottier G, Rustique E, et al.
J Biomed Opt
. 2013 Aug;
18(10):101311.
PMID: 23900442
A new contrast agent, LipImage™ 815, has been designed and compared to previously described indocyanine green (ICG)-loaded lipid nanoparticles (ICG-lipidots®). Both contrast agents display similar size (50-nm diameter), zeta potential,...
10.
Keramidas M, De Fraipont F, Karageorgis A, Moisan A, Persoons V, Richard M, et al.
Stem Cell Res Ther
. 2013 May;
4(2):41.
PMID: 23628074
Introduction: Understanding the multiple biological functions played by human mesenchymal stem cells (hMSCs) as well as their development as therapeutics in regenerative medicine or in cancer treatment are major fields...